SCHEMBL6528481

SCHEMBL6528481

COc1cccc(C[CH]c2c[nH]cn2)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 1/20 0.43
TAAR1 Q96RJ0 3/20 0.42
IDO1 P14902 2/20 0.42
AGXT P21549 2/20 0.42
FGFR1 P11362 1/20 0.41
FGFR4 P22455 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
MAOB P27338 3/20 0.41
POLB P06746 1/20 0.40
QPCT Q16769 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
CDC7 O00311 1/20 0.39
DBF4 Q9UBU7 1/20 0.39
CMA1 P23946 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11202432 0.86 IDO1 (0.43) HTR1BTAAR1IDO1AGXTFGFR1
SCHEMBL6530140 0.82 ALDH1A1 (0.46) TAAR1IDO1AGXTSIGMAR1MAOB
SCHEMBL6528671 0.78 PNMT (0.40) TAAR1IDO1AGXTCDC7DBF4
SCHEMBL11206445 0.77 CHRM2 (0.44) TAAR1IDO1AGXTSIGMAR1CHRM2
SCHEMBL1196870 0.77 MAOB (0.40) TAAR1MAOBHRH3CDC7DBF4
SCHEMBL2103486 0.75 FGFR1 (0.50) HTR1BTAAR1IDO1AGXTFGFR1
SCHEMBL224560 0.74 TAAR1 (0.51) TAAR1SIGMAR1CHRM2CHRM1CHRM3
SCHEMBL248658 0.73 CHRM2 (0.57) TAAR1IDO1AGXTSIGMAR1MAOB
SCHEMBL6529172 0.71 IDO1 (0.39) TAAR1IDO1SIGMAR1CHRM2CHRM1
SCHEMBL8305017 0.71 TAAR1 (0.58) TAAR1IDO1AGXTSIGMAR1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed